Latest filing published 26 May 2023 for Silo Pharma, Inc., €1,983.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -7.3%Entry US$31.73 · Close at T+365 US$29.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Daniel E. Ryweck: trading record in brief
Daniel E. Ryweck discloses dealings in 2 companies, chiefly KonaTel, Inc. and Silo Pharma, Inc. In total, 2 filings cover trades dated from 25 July 2017 to 26 May 2023.
Every open-market trade on record is a purchase: 1 purchase worth €1,983, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. Since January 2023: 1 purchase and no sales on the market.
The record was last updated on 26 May 2023 with an open-market purchase (€1,983) in Silo Pharma, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Daniel E. Ryweck
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$2.1264100.0% of flowCommon StockSEC:0001213900-23-043531:0Canonical exit: 24 Aug 2023 (T+90)
- 50,000 shares@ US$0.0338100.0% of flowCommon StockSEC:0001010412-17-000042:0
2 of 2 declarations